The U.S. Food and Drug Administration (FDA) recently announced that AndroGel manufacturers would be required to add heart attack and stroke risks to the drug’s warning label, but AndroGel lawsuits are already underway.
Lawyers began filing testosterone lawsuits last year on behalf of men who suffered a heart attack or stroke while taking prescription testosterone. There are 14 manufacturers in the two-billion-dollar market. In June 2014, a centralized Testosterone multidistrict litigation (MDL) was established in Chicago so that testosterone lawsuits involving all 14 manufactures could be filed in one place. Continue Reading